Profits included those of Meriden Animal Health, which was acquired in March. “The group’s performance is very encouraging, despite the disruption in European and Middle Eastern regions, and demonstrates the resilience of our geographic spread," said company Chairman Richard Rose. "The recent acquisition of Meriden Animal Health Limited has further bolstered our product range and the business is performing to plan. I am particularly pleased with the successful repositioning of the UK agriculture division, which is now focused on value-added feed additives, and Vitrition, our organic feed business, which is performing very well.”
The goal of the second half is maintaining the progress of the first and the group’s overall performance is in line with its budget, according to the company. "We are very pleased with the acquisition of Meriden, which broadens our product range and increases our global market share in key feed additive markets," said Rose. "Meriden is integrating well and will contribute fully to the group’s second-half performance. We remain focused on delivering organic growth through strong territory management, innovative product development and by supplementing these initiatives, from time to time, with suitable acquisition opportunities."